Emmanuelle Dernis

Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger et al. · JAMA · 2016 · 189 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

Maxime Dougados, Martin Soubrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2014 · 160 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

Bruno Fautrel, Thao Pham, Toni Alfaiate et al. · Annals of the Rheumatic Diseases · 2015 · 147 citations

Medicine, Immunology, Pharmacotherapy +16

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

Raphaèle Séror, Christophe Richez, Christelle Sordet et al. · Lara D. Veeken · 2013 · 143 citations

Medicine, Immunology, Neurology +13

New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases

Daniel Wendling, Julien Paccou, Jean‐Marie Berthelot et al. · Seminars in Arthritis and Rheumatism · 2011 · 140 citations

Medicine, Clinical Sciences, Immunology +16